Asymptomatic small intestinal ulcerative lesions: Obesity and Helicobacter pylori are likely to be risk factors.
Fujimori S.
World J Gastroenterol. 2021 Jul 28;27(28):4484-4492. doi: 10.3748/wjg.v27.i28.4484.
Risk factors for small-intestinal mucosal breaks beyond aspirin.
Sun X, Wang F, Liu J, Wu L, Wang Z, Chen X, Wang M, Zeng Q.
J Gastroenterol Hepatol. 2022 Aug;37(8):1596-1602. doi: 10.1111/jgh.15892. Epub 2022 May 31.
Distribution of small intestinal mucosal injuries as a result of NSAID administration.
Fujimori S, Gudis K, Takahashi Y, Seo T, Yamada Y, Ehara A, Kobayashi T, Mitsui K, Yonezawa M, Tanaka S, Tatsuguchi A, Sakamoto C.
Eur J Clin Invest. 2010 Jun;40(6):504-10. doi: 10.1111/j.1365-2362.2010.02290.x. Epub 2010 Apr 14.
Lactobacillus complex capsules ameliorate aspirin-related small intestinal mucosal injury: a prospective, randomized, controlled clinical trial.
Chen X, Gao F, Zhang J.
Scand J Gastroenterol. 2022 Oct;57(10):1195-1201. doi: 10.1080/00365521.2022.2073184. Epub 2022 May 9.
Microbiota Plays a Key Role in Non-Steroidal Anti-Inflammatory Drug-Induced Small Intestinal Damage.
Otani K, Tanigawa T, Watanabe T, Shimada S, Nadatani Y, Nagami Y, Tanaka F, Kamata N, Yamagami H, Shiba M, Tominaga K, Fujiwara Y, Arakawa T.
Digestion. 2017;95(1):22-28. doi: 10.1159/000452356. Epub 2017 Jan 5.
Short article: Small intestinal mucosal injury in patients taking chemotherapeutic agents for solid cancers.
Dore MP, Pes GM, Murino A, Quarta Colosso B, Pennazio M.
Eur J Gastroenterol Hepatol. 2017 May;29(5):568-571. doi: 10.1097/MEG.0000000000000828.
Visible small-intestinal mucosal injury in chronic NSAID users.
Graham DY, Opekun AR, Willingham FF, Qureshi WA.
Clin Gastroenterol Hepatol. 2005 Jan;3(1):55-9. doi: 10.1016/s1542-3565(04)00603-2.
Irsogladine improves small-intestinal injuries in regular users of nonsteroidal anti-inflammatory drugs.
Isomura Y, Yamaji Y, Yamada A, Watanabe Y, Suzuki H, Kobayashi Y, Yoshida S, Watabe H, Hirata Y, Yoshida H, Koike K.
Gastrointest Endosc. 2014 Jul;80(1):118-25. doi: 10.1016/j.gie.2013.12.030. Epub 2014 Feb 8.
Sulforaphane protects small intestinal mucosa from aspirin/NSAID-induced injury by enhancing host defense systems against oxidative stress and by inhibiting mucosal invasion of anaerobic enterobacteria.
Yanaka A, Sato J, Ohmori S.
Curr Pharm Des. 2013;19(1):157-62. doi: 10.2174/13816128130120.
Doxycycline-induced gastrointestinal injury.
Affolter K, Samowitz W, Boynton K, Kelly ED.
Hum Pathol. 2017 Aug;66:212-215. doi: 10.1016/j.humpath.2017.02.011. Epub 2017 Mar 9.
